These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bacillary dysentery. An institutional outbreak of Shigella sonnei: treatment of 36 cases with nalidixic acid. Fernandez LA. J Kans Med Soc; 1966 Jul; 67(7):359-60 passim. PubMed ID: 5330682 [No Abstract] [Full Text] [Related]
3. [Therapeutic effectiveness of nevigramon in the complex treatment of acute dysentery]. Gebesh VV, Koval'chuk VK, Ianushevskaia RI, Sofienko NIa, Lysak LI. Vrach Delo; 1980 May; (5):110-3. PubMed ID: 6994350 [No Abstract] [Full Text] [Related]
4. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy. Cheasty T, Day M, Threlfall EJ. Clin Microbiol Infect; 2004 Nov; 10(11):1033-5. PubMed ID: 15522014 [Abstract] [Full Text] [Related]
6. A clinical study of wintomylon in the treatment of shigellosis. Yu PC, Chen HS. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1965 Nov; 6(3):127-31. PubMed ID: 5861506 [No Abstract] [Full Text] [Related]
11. Randomized clinical trial of norfloxacin for shigellosis. Bhattacharya SK, Bhattacharya MK, Dutta P, Sen D, Rasaily R, Moitra A, Pal SC. Am J Trop Med Hyg; 1991 Dec 24; 45(6):683-7. PubMed ID: 1763794 [Abstract] [Full Text] [Related]
17. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults. Rogerie F, Ott D, Vandepitte J, Verbist L, Lemmens P, Habiyaremye I. Antimicrob Agents Chemother; 1986 May 24; 29(5):883-6. PubMed ID: 3524434 [Abstract] [Full Text] [Related]